Speakers from Touchstone Exploration, Shanta Gold, Savannah Resources and Kavango Resources feature in our Natural Resources webinar on May 25th. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7,930.00
Bid: 7,939.00
Ask: 7,940.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.01%)
Open: 7,920.00
High: 7,971.00
Low: 7,901.00
Yest. Close: 7,895.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

AstraZeneca's Imfinzi Gets US Review That Could Halve Medical Visits

Tue, 18th Aug 2020 08:14

(Alliance News) - AstraZeneca PLC on Tuesday said its Imfinzi has been accepted for its supplemental biologics license application by the Food & Drug Administration and has been granted priority review for a less-frequent dose regiment for the treatment of non-small cell lung cancer and bladder cancer.

The biopharmaceutical company's Imfinzi could be administered intravenously every four weeks if it is approved. This would effectively half the number of medical visits patients would have to undergo.

Imfinzi is a human anitbody which counters a tumour's immune-evading abilities.

Imfinzi would be administered at a fixed dose for stage 3 non-small-cell lung carcinoma after chemoradiation therapy and previously treated advanced bladder cancer.

The FDA only grants priority review status to medicines which offer significant advances over available options by demonstrating safety or efficacy improvements, preventing serious conditions, or enhancing patient compliance.

The supplemental biologics license application was based on data from numerous Imfinzi clinical trials.

Dave Fredrickson, head of the Oncology Business Unit at Astra, said: "The new less-frequent dosing option for non-small cell lung cancer and bladder cancer will simplify and improve treatment by enabling continuity of care while minimising the risk of exposure to infection in the healthcare setting. This takes on particular urgency during the current pandemic, as doctors care for patients at high risk of Covid-19 complications."

AstraZeneca shares were down 0.3% at 8,553.00 pence each on Tuesday morning in London.

By Greg Roxburgh; gregroxburgh@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News

UPDATE 1-Spain approves Pfizer shots for under-60s who got AstraZeneca first dose -El Pais

(Updates with reported approval)MADRID, May 18 (Reuters) - Spain's public health commission has approved a proposal by the health ministry that Spaniards under 60 who have received a first dose of AstraZeneca's vaccine get a second shot of the cor...

18 May 21 21:46

Spain proposes Pfizer shots for under-60s who got Astrazeneca first dose, El Pais says

MADRID, May 18 (Reuters) - Spain's Health Ministry has proposed that people under 60 who have already received a first dose of AstraZeneca's drug receive a second shot of the coronavirus vaccine produced by Pfizer, El Pais newspaper reported on T...

18 May 21 19:23

Tuesday broker round-up

(Sharecast News) - BP: Barclays upgrades to top pick with a target price of 475p.

18 May 21 14:00

UPDATE 1-Spanish study finds AstraZeneca vaccine followed by Pfizer dose is safe and effective

(Adds detail, quotes)MADRID, May 18 (Reuters) - A Spanish study on mixing COVID-19 vaccines has found that giving a dose of Pfizer's drug to people who already received a first shot of AstraZeneca vaccine is highly safe and effective, preliminary...

18 May 21 12:31

Oxford Biomedica jumps after AstraZeneca orders more Covid-19 vaccines

Oxford Biomedica jumps after AstraZeneca orders more Covid-19 vaccines

18 May 21 11:52

Spanish study finds AstraZeneca vaccine followed by Pfizer dose is safe and effective

MADRID, May 18 (Reuters) - A Spanish study on mixing COVID-19 vaccines has found that giving a dose of Pfizer's drug to people who already received a first shot of AstraZeneca vaccine is highly safe and effective, the researchers said on Tuesday....

18 May 21 10:59

UPDATE 2-FTSE 100 flat as Vodafone loss offsets gains in banks; Oxford Biomedica shines

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* Oxford Biomedica rises on robust outlook* Vodafone drops after missing earnings expectations* FTSE 100 up 0.2%, FTSE 250 adds 0.6% (Update...

18 May 21 09:23

Oxford Biomedica ups revenue forecast as AstraZeneca lifts vaccine output

(Sharecast News) - Gene and cell therapy group Oxford Biomedica on Tuesday doubled annual earnings guidance after pharmaceutical giant AstraZeneca ordered more Covid-19 vaccines.

18 May 21 08:13

LONDON MARKET PRE-OPEN: Phoenix Group confirms talks for European sale

LONDON MARKET PRE-OPEN: Phoenix Group confirms talks for European sale

18 May 21 07:47

Brazil to receive ingredients from China for 25 million vaccine shots in coming days

BRASILIA, May 17 (Reuters) - Brazil will receive ingredients from China to produce up to 25 million doses of the AstraZeneca and Sinovac COVID-19 vaccines on Saturday and early next week, Health Ministry and political officials said on Monday.Rod...

17 May 21 19:33

UPDATE 1-Biden to announce U.S. will send 20 mln vaccines abroad by end of June

(Adds background, further Psaki comment)By Trevor HunnicuttWASHINGTON, May 17 (Reuters) - U.S. President Joe Biden plans to announce on Monday that he will send at least 20 million COVID-19 vaccine doses to other countries by the end of June, mark...

17 May 21 18:00

UPDATE 2-Biden to send U.S.-authorized vaccines abroad for first time

(Updates with announcement; adds details on vaccines used in U.S.)By Trevor Hunnicutt and Steve HollandWASHINGTON, May 17 (Reuters) - U.S. President Joe Biden announced on Monday that he will send at least 20 million COVID-19 vaccine doses to othe...

17 May 21 18:00

UPDATE 3-Biden to send 20 mln doses of U.S.-authorized vaccines abroad for first time

(Updates with additional Biden quotes and details)By Steve HollandWASHINGTON, May 17 (Reuters) - President Joe Biden will send at least 20 million more COVID-19 vaccine doses abroad by the end of June, marking the first time the United States is sh...

17 May 21 18:00

UPDATE 4-Biden to send 20 mln doses of U.S.-authorized vaccines abroad for first time

(Adds China's comments, vaccine export)By Steve HollandWASHINGTON, May 17 (Reuters) - President Joe Biden will send at least 20 million more COVID-19 vaccine doses abroad by the end of June, marking the first time the United States is sharing vacc...

17 May 21 18:00

UPDATE 1-WHO chief urges COVID-19 vaccine makers to advance doses for COVAX

(Adds details)By Emma FargeGENEVA, May 17 (Reuters) - The head of the World Health Organization called on manufacturers to make COVID-19 vaccine doses available to the COVAX vaccine-sharing facility earlier than planned due to a supply shortfall l...

17 May 21 15:36

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.